Researchers at Stanford University Medical School studied melanoma in 60,000 Caucasian women.
Over 12 years, the study showed women who took aspirin at least a few times a week had a 20 percent lower risk of developing melanoma.
Those who took aspirin regularly had a 30 percent lower risk.
The study appears in the journal "Cancer."